Cargando…

Secretoneurin as a Novel Biomarker of Cardiovascular Episodes: Are We There Yet? A Narrative Review

Secretoneurin (SN) is a 33 amino-acid evolutionary conserved neuropeptide from the chromogranin peptide family. SN’s main effects may be cardioprotective and are believed to be mediated through its inhibition of calmodulin-dependent kinase II (CaMKII), which influences intracellular calcium handling...

Descripción completa

Detalles Bibliográficos
Autores principales:	Plášek, Jiří, Lazárová, Marie, Dodulík, Jozef, Šulc, Patrik, Stejskal, David, Švagera, Zdeněk, Všianský, František, Václavík, Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9735894/ https://www.ncbi.nlm.nih.gov/pubmed/36498765 http://dx.doi.org/10.3390/jcm11237191

Ejemplares similares

Assessment of Intrathecal Free Light Chain Synthesis: Comparison of Different Quantitative Methods with the Detection of Oligoclonal Free Light Chains by Isoelectric Focusing and Affinity-Mediated Immunoblotting
por: Zeman, David, et al.
Publicado: (2016)

Conditional knockout of the secretogranin II gene to reveal biological functions of secretoneurin
por: Leierer, Johannes, et al.
Publicado: (2008)

Secretoneurin A Directly Regulates the Proteome of Goldfish Radial Glial Cells In Vitro
por: Da Fonte, Dillon F., et al.
Publicado: (2018)

FRI290 Proteomic Identification Of Secretoneurin-Stimulated Proteins In Purified Mouse Gonadotropes
por: Herdman, Ashley, et al.
Publicado: (2023)

Slittable sheath supported right ventricular pacing lead implantation in persistent left superior vena cava with absent right superior vena cava: a case report
por: Plášek, Jiří, et al.
Publicado: (2023)

Desmoglein 2 Depletion Leads to Increased Migration and Upregulation of the Chemoattractant Secretoneurin in Melanoma Cells
por: Peitsch, Wiebke K., et al.
Publicado: (2014)

Manufacturing of a Secretoneurin Drug Delivery System with Self-Assembled Protamine Nanoparticles by Titration
por: Scheicher, Bernhard, et al.
Publicado: (2016)

Evaluation of Serum Secretoneurin Levels in Patients With Ischemic Stroke Who Underwent Mechanical Thrombectomy
por: Güngör, İremgül, et al.
Publicado: (2023)

Clinical Applications for Gasotransmitters in the Cardiovascular System: Are We There Yet?
por: Arrigo, Elisa, et al.
Publicado: (2023)

Are we there yet?
por: Wise, Jo Ann
Publicado: (2015)

Are we there yet?
por: Swann, Nicole
Publicado: (2019)

Are we there yet?
por: McCann, Shaun R.
Publicado: (2022)

Secretoneurin A regulates neurogenic and inflammatory transcriptional networks in goldfish (Carassius auratus) radial glia
por: Da Fonte, Dillon F., et al.
Publicado: (2017)

Effects of Secretoneurin and Gonadotropin-Releasing Hormone Agonist on the Spawning of Captive Greater Amberjack (Seriola dumerili)
por: Song, Yanlong, et al.
Publicado: (2022)

The novel angiogenic cytokine secretoneurin promotes angiogenesis, arteriogenesis and vasculogenesis in the mouse hind-limb ischemia model
por: Schgoer, Wilfried, et al.
Publicado: (2008)

Investigation of secretoneurin as a potential biomarker of brain injury in very preterm infants: A pilot study
por: Posod, Anna, et al.
Publicado: (2023)

Breath Tests Used in the Context of Bariatric Surgery
por: Karas, Daniel, et al.
Publicado: (2022)

Are we nearly there yet?
por: Battersby, Stephen
Publicado: (2005)

Why Are We Not There Yet?
por: Wenger, Nanette K.
Publicado: (2021)

COVID-19 associated coagulopathy: Mechanisms and host-directed treatment
por: Plášek, Jiří, et al.
Publicado: (2022)

The Agreement of a Two- and a Three-Dimensional Speckle-Tracking Global Longitudinal Strain
por: Plášek, Jiří, et al.
Publicado: (2022)

Humanized mice: are we there yet?
por: Macchiarini, Francesca, et al.
Publicado: (2005)

Cancer vaccines: Are we there yet?
por: Hanna, Jr., Michael G.
Publicado: (2012)

Cancer immunotherapy: are we there yet?
por: Li, Zihai, et al.
Publicado: (2013)

Myocardial Inflammation—Are We There Yet?
por: Greulich, Simon, et al.
Publicado: (2015)

The Artificial Pancreas: Are We There Yet?
por: Cefalu, William T., et al.
Publicado: (2014)

Regenerative medicine: are we there yet?
por: Badylak, Stephen, et al.
Publicado: (2017)

Peak MSC—Are We There Yet?
por: Olsen, Timothy R., et al.
Publicado: (2018)

Dracunculiasis Eradication: Are We There Yet?
por: Hopkins, Donald R., et al.
Publicado: (2018)

Robotics and ophthalmology: Are we there yet?
por: Pandey, Suresh K, et al.
Publicado: (2019)

Precision Oncology: Are We There Yet?
Publicado: (2017)

Biomarkers for SUDEP: Are We There Yet?
por: King-Stephens, David
Publicado: (2019)

Safe Nanoparticles: Are We There Yet?
por: Najahi-Missaoui, Wided, et al.
Publicado: (2020)

Secretoneurin Gene Therapy Improves Blood Flow in an Ischemia Model in Type 1 Diabetic Mice by Enhancing Therapeutic Neovascularization
por: Schgoer, Wilfried, et al.
Publicado: (2013)

Prion propagation in vitro: are we there yet?
por: Ryou, Chongsuk, et al.
Publicado: (2008)

Personalized medicine for asthma: Are we there yet?
por: Poon, Audrey H., et al.
Publicado: (2012)

RNA-Seq Assembly – Are We There Yet?
por: Schliesky, Simon, et al.
Publicado: (2012)

Predicting cancer drivers: are we there yet?
por: Krishnan, Vidhya G, et al.
Publicado: (2012)

Immunometabolism in Obese Asthmatics: Are We There Yet?
por: Periyalil, Hashim A., et al.
Publicado: (2013)

Dexmedetomidine use in the ICU: Are we there yet?
por: Ahmed, Shakeel, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_p6419e39ooe4ffplvlrdoudj5m